Adopting a new approach to treat refractory or resistant viral infections in solid organ transplant recipients

Adopting a new approach to treat refractory or resistant viral infections in solid organ transplant recipients

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Transplant infectious disease 2023-12, Vol.25 (6), p.e14161-n/a
Hauptverfasser: Probst, Varvara, Thomas, Sanya J., Ouellette, Christopher P.
Format: Artikel
Sprache:eng
Schlagworte:
Antiviral Agents - therapeutic use
Humans
Organ Transplantation - adverse effects
Transplant Recipients
Virus Diseases - drug therapy
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page n/a
container_issue 6
container_start_page e14161
container_title Transplant infectious disease
container_volume 25
creator Probst, Varvara
Thomas, Sanya J.
Ouellette, Christopher P.
description
doi_str_mv 10.1111/tid.14161
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2873253923</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2904961894</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3481-3735ad59389aca28a3165db804fa35578632b1098c147609925b682e501c08843</originalsourceid><addsrcrecordid>eNp1kctOAyEUhonR2HpZ-AKGxI0upnIZZmDZ1Gti4kbXhDK00kxhBGrTt5d2qgsT2XBIPr6cc34ALjAa4Xxuk21GuMQVPgBDTIUoKKrI4a7mBSE1HYCTGBcI4VqU4hgMaF0LihgbAjdufJesm0MFnVlD1XXBK_0Bk4cpGJVgMLOgdPJhA33Ir2hjUi7BLxtUC62bGZ2sdzGXMPrWNhmbK5d_Kxe7dosGo21njUvxDBzNVBvN-f4-Be8P92-Tp-Ll9fF5Mn4pNC05LmhNmWqYoFworQhXFFesmXJUzhRlrOYVJVOMBNe4rCskBGHTihPDENaI85Keguvem6f5XJmY5NJGbdrcjvGrKAmvKWFUEJrRqz_owq-Cy91JIlApKszFVnjTUzr4GPNOZBfsUoWNxEhuQ5A5BLkLIbOXe-NqujTNL_mz9Qzc9sDatmbzv0m-Pd_1ym-H4ZAJ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2904961894</pqid></control><display><type>article</type><title>Adopting a new approach to treat refractory or resistant viral infections in solid organ transplant recipients</title><source>MEDLINE</source><source>Access via Wiley Online Library</source><creator>Probst, Varvara ; Thomas, Sanya J. ; Ouellette, Christopher P.</creator><creatorcontrib>Probst, Varvara ; Thomas, Sanya J. ; Ouellette, Christopher P.</creatorcontrib><identifier>ISSN: 1398-2273</identifier><identifier>EISSN: 1399-3062</identifier><identifier>DOI: 10.1111/tid.14161</identifier><identifier>PMID: 37793055</identifier><language>eng</language><publisher>Denmark: Wiley Subscription Services, Inc</publisher><subject>Antiviral Agents - therapeutic use ; Humans ; Organ Transplantation - adverse effects ; Transplant Recipients ; Virus Diseases - drug therapy</subject><ispartof>Transplant infectious disease, 2023-12, Vol.25 (6), p.e14161-n/a</ispartof><rights>2023 Wiley Periodicals LLC.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c3481-3735ad59389aca28a3165db804fa35578632b1098c147609925b682e501c08843</cites><orcidid>0000-0003-1607-9537 ; 0000-0001-7037-4022</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1111%2Ftid.14161$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1111%2Ftid.14161$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>315,781,785,1418,27929,27930,45579,45580</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/37793055$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Probst, Varvara</creatorcontrib><creatorcontrib>Thomas, Sanya J.</creatorcontrib><creatorcontrib>Ouellette, Christopher P.</creatorcontrib><title>Adopting a new approach to treat refractory or resistant viral infections in solid organ transplant recipients</title><title>Transplant infectious disease</title><addtitle>Transpl Infect Dis</addtitle><subject>Antiviral Agents - therapeutic use</subject><subject>Humans</subject><subject>Organ Transplantation - adverse effects</subject><subject>Transplant Recipients</subject><subject>Virus Diseases - drug therapy</subject><issn>1398-2273</issn><issn>1399-3062</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp1kctOAyEUhonR2HpZ-AKGxI0upnIZZmDZ1Gti4kbXhDK00kxhBGrTt5d2qgsT2XBIPr6cc34ALjAa4Xxuk21GuMQVPgBDTIUoKKrI4a7mBSE1HYCTGBcI4VqU4hgMaF0LihgbAjdufJesm0MFnVlD1XXBK_0Bk4cpGJVgMLOgdPJhA33Ir2hjUi7BLxtUC62bGZ2sdzGXMPrWNhmbK5d_Kxe7dosGo21njUvxDBzNVBvN-f4-Be8P92-Tp-Ll9fF5Mn4pNC05LmhNmWqYoFworQhXFFesmXJUzhRlrOYVJVOMBNe4rCskBGHTihPDENaI85Keguvem6f5XJmY5NJGbdrcjvGrKAmvKWFUEJrRqz_owq-Cy91JIlApKszFVnjTUzr4GPNOZBfsUoWNxEhuQ5A5BLkLIbOXe-NqujTNL_mz9Qzc9sDatmbzv0m-Pd_1ym-H4ZAJ</recordid><startdate>202312</startdate><enddate>202312</enddate><creator>Probst, Varvara</creator><creator>Thomas, Sanya J.</creator><creator>Ouellette, Christopher P.</creator><general>Wiley Subscription Services, Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QO</scope><scope>7U9</scope><scope>8FD</scope><scope>FR3</scope><scope>H94</scope><scope>K9.</scope><scope>M7N</scope><scope>P64</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0003-1607-9537</orcidid><orcidid>https://orcid.org/0000-0001-7037-4022</orcidid></search><sort><creationdate>202312</creationdate><title>Adopting a new approach to treat refractory or resistant viral infections in solid organ transplant recipients</title><author>Probst, Varvara ; Thomas, Sanya J. ; Ouellette, Christopher P.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3481-3735ad59389aca28a3165db804fa35578632b1098c147609925b682e501c08843</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>Antiviral Agents - therapeutic use</topic><topic>Humans</topic><topic>Organ Transplantation - adverse effects</topic><topic>Transplant Recipients</topic><topic>Virus Diseases - drug therapy</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Probst, Varvara</creatorcontrib><creatorcontrib>Thomas, Sanya J.</creatorcontrib><creatorcontrib>Ouellette, Christopher P.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Biotechnology Research Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Transplant infectious disease</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Probst, Varvara</au><au>Thomas, Sanya J.</au><au>Ouellette, Christopher P.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Adopting a new approach to treat refractory or resistant viral infections in solid organ transplant recipients</atitle><jtitle>Transplant infectious disease</jtitle><addtitle>Transpl Infect Dis</addtitle><date>2023-12</date><risdate>2023</risdate><volume>25</volume><issue>6</issue><spage>e14161</spage><epage>n/a</epage><pages>e14161-n/a</pages><issn>1398-2273</issn><eissn>1399-3062</eissn><cop>Denmark</cop><pub>Wiley Subscription Services, Inc</pub><pmid>37793055</pmid><doi>10.1111/tid.14161</doi><tpages>3</tpages><orcidid>https://orcid.org/0000-0003-1607-9537</orcidid><orcidid>https://orcid.org/0000-0001-7037-4022</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1398-2273
ispartof Transplant infectious disease, 2023-12, Vol.25 (6), p.e14161-n/a
issn 1398-2273
1399-3062
language eng
recordid cdi_proquest_miscellaneous_2873253923
source MEDLINE; Access via Wiley Online Library
subjects Antiviral Agents - therapeutic use
Humans
Organ Transplantation - adverse effects
Transplant Recipients
Virus Diseases - drug therapy
title Adopting a new approach to treat refractory or resistant viral infections in solid organ transplant recipients
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-12T00%3A55%3A17IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Adopting%20a%20new%20approach%20to%20treat%20refractory%20or%20resistant%20viral%20infections%20in%20solid%20organ%20transplant%20recipients&rft.jtitle=Transplant%20infectious%20disease&rft.au=Probst,%20Varvara&rft.date=2023-12&rft.volume=25&rft.issue=6&rft.spage=e14161&rft.epage=n/a&rft.pages=e14161-n/a&rft.issn=1398-2273&rft.eissn=1399-3062&rft_id=info:doi/10.1111/tid.14161&rft_dat=%3Cproquest_cross%3E2904961894%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2904961894&rft_id=info:pmid/37793055&rfr_iscdi=true